Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
Over 50? Join the PREDICTOM Study and Help Advance Brain Health!
Would you like to help us understand how to reduce the risk of developing Alzheimer’s Disease?
News
PREDICTOM Launches Standardized MRI Protocol to Detect Early Alzheimer’s Risk
PREDICTOM has unveiled a standardized MRI protocol designed to identify early biomarkers of Alzheimer’s disease. With dementia cases in the EU projected to double by 2050, early detection is more critical than ever.
News
New study reveals subtle brain network changes in early Alzheimer’s
A new study from the European research project PREDICTOM shows that even small memory problems can be linked to early changes in the brain, changes that can be measured with a simple brain scan.
Did you know that you can reduce your risk of developing dementia?
The risk of developing dementia is influenced by various factors, with several of them being modifiable by the actions we take on a daily basis. On this page you can learn more about what actions you can take to reduce your risk.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.